SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is capturing significant market attention as it prepares for an earnings report that acts as a major bellwether for the entire AI infrastructure sector, with investors intensely debating whether the company can sustain its growth or if it will face a typical post-earnings sell-off. Community discussions are centered on whether the AI trade is peaking, with many traders closely watching for signals on hyperscaler spending, data center demand, and potential competitive pressures to determine if the stock will trigger a broader market move.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate the potential for a turnaround, fueled by recent insider buying, rumors of favorable tariff adjustments, and anticipation for the upcoming World Cup. While some market participants express deep pessimism over declining margins and market share, others are actively accumulating shares as a long-term value play at multi-year lows.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing significant upward momentum and trending interest as investors anticipate the imminent 80th trial event for its REGAL Phase 3 clinical trial in acute myeloid leukemia. The community is actively discussing a potential short squeeze and institutional accumulation, fueled by optimistic management commentary regarding the immunotherapy platform's curative potential and survival data.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the FDA's acceptance of their supplemental BLA for ANKTIVA, which sets a PDUFA target date of January 6, 2027, to expand treatment options for BCG-unresponsive papillary-only bladder cancer. The community is actively debating the significance of the 10-month regulatory timeline against the urgency of the medical crisis, while highlighting how NCCN Category 2A guideline support is already facilitating patient access.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing intense selling pressure as institutional liquidation and a sharp rise in global bond yields overshadow the metal's long-term industrial demand narrative. While some investors view the volatility as a potential buying opportunity, community sentiment remains deeply divided between those expecting a deeper correction and those betting on a rapid recovery fueled by inflationary risks.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as investors react to a significant earnings beat and an optimistic full-year outlook, fueling debate over the company's turnaround progress under its new leadership. The community is actively discussing the stock's recent price recovery, comparing it to rival Walmart, and debating whether the rebound is a sustainable shift or a potential overextension.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors weigh significant analyst upgrades and record stake increases from major institutions against persistent concerns regarding market manipulation and the competitive EV landscape in China. The community remains deeply polarized, with many retail shareholders expressing extreme frustration over the stock's long-term performance while others aggressively accumulate shares in anticipation of a potential short squeeze following the upcoming earnings report.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant volatility as traders debate whether the stock is undergoing a long-term valuation reset or a brief consolidation period amid broader sector rotation. Sentiment remains polarized, with many investors closely watching the companys enterprise AI and cloud performance while others express frustration over institutional hedging and erratic intraday price action.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users fiercely debate the company's financial stability, ongoing regulatory hurdles, and its alignment with political controversies surrounding the former president. The stock remains a focal point for intense sentiment, with community members polarized between accusations of corporate mismanagement and grifting, and vocal support for the brand's role in the current political landscape.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is surging following a strong earnings report that featured a beat on both revenue and earnings, alongside an upward revision of their full-year guidance. The community is actively debating the stock's high valuation relative to its growth, with bulls highlighting the company's rapid expansion and store traffic, while bears express skepticism toward its premium pricing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 62.5% in Nuvectis Pharma (NVCT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Nuvectis Pharma (NASDAQ:NVCT) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04...

Nuvectis Pharma (NVCT) Projected to Post Earnings on Tuesday

Nuvectis Pharma (NASDAQ:NVCT) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-nuvectis-pharma-inc-stock...

Nuvectis Pharma, Inc. $NVCT Shares Acquired by Iridian Asset Management LLC CT

Iridian Asset Management LLC CT increased its holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) by 44.5% during the fourth quarter, according to its most recent filing with the Securities...

Nuvectis Pharma (NASDAQ:NVCT) Trading Down 1.7%  - Here's What Happened

Nuvectis Pharma (NASDAQ:NVCT) Shares Down 1.7% - What's Next...

Nuvectis Pharma (NASDAQ:NVCT) Shares Up 6.3% - Still a Buy?

Nuvectis Pharma (NASDAQ:NVCT) Shares Up 6.3% - Still a Buy...

Nuvectis Pharma (NVCT) to Release Quarterly Earnings on Tuesday

Nuvectis Pharma (NASDAQ:NVCT) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 24. (View Earnings Report at...

HC Wainwright Forecasts Weaker Earnings for Nuvectis Pharma

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - Stock analysts at HC Wainwright reduced their FY2026 earnings estimates for Nuvectis Pharma in a research report issued on Wednesday, February...

HC Wainwright Predicts Nuvectis Pharma Q1 Earnings

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 EPS estimates for Nuvectis Pharma in a research note issued on Wednesday, February 11th. HC...

Nuvectis Pharma (NASDAQ:NVCT) Trading Up 5.8% - Should You Buy?

Nuvectis Pharma (NASDAQ:NVCT) Stock Price Up 5.8% - Should You Buy...

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.26	--	--	N/A
Q1 '26	-$0.31	-$0.26	17.20%	BEAT
Q4 '25	-$0.32	-$0.31	1.90%	BEAT
Q3 '25	-$0.25	-$0.44	-76.00%	MISSED
Q2 '25	-$0.25	-$0.30	-19.21%	MISSED

NVCT
Nuvectis Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest NVCT News

NVCTNuvectis Pharma Inc